Marilyn Li

Dr. Marilyn Li is responsible for providing clinical application of high-throughput molecular technologies for integrated cancer genomic diagnosis, liquid biopsy for cancer screen, risk stratification and monitoring, characterization of tumorigenesis roles of novel fusions identified during RNA-seq of tumor tissues and molecular diagnosis for all projects within the clinical trials unit of D³b.

Data Science, Clinical Research, Pathology